fluorodeoxyglucose f18 has been researched along with Adrenal Gland Hyperfunction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacanovic, S; Burger, IA; Hafner, J; Huellner, MW; Stolzmann, P | 1 |
Balsa-Bretón, MÁ; Guijarro-Armas, G; Merino-Viveros, M; Pavón-Paz, I; Penín-Gonzalez, FJ; Rosado-Sierra, JA | 1 |
Alencar, GA; Fragoso, MC; Lerario, AM; Mendonca, BB; Yamaga, LY | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Adrenal Gland Hyperfunction
Article | Year |
---|---|
[Use of 18F-FDG-positron emission tomography in presurgical evaluation of nonspecific or suspectious adrenal masses in non-oncologic patients].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Hyperfunction; Adult; Aged; Area Under Curve; Carcinoma; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2016 |
2 other study(ies) available for fluorodeoxyglucose f18 and Adrenal Gland Hyperfunction
Article | Year |
---|---|
Ipilimumab-Induced Adrenalitis: A Possible Pitfall in 18F-FDG-PET/CT.
Topics: Adrenocortical Hyperfunction; Aged; Antibodies, Monoclonal; Antineoplastic Agents; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Ipilimumab; Male; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
(18)F-FDG-PET/CT imaging of ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) demonstrating increased (18)F-FDG uptake.
Topics: Adrenal Cortex; Adrenocortical Hyperfunction; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Middle Aged; Positron-Emission Tomography | 2011 |